HMS — Q4 and FY2013 Earnings Presentation
18 slides from HMS's earnings presentation, Feb 28, 2014
Slide 1: Q4 and Full Year 2013 Investor Call
Q4 and Full Year 2013 Investor Call February 28, 2014 Bill Lucia, President and CEO Walter Hosp, CFO
Slide 2: Safe Harbor Statement
Safe Harbor Statement 2 This presentation contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 These forward-looking statements are based on current expectations, estimates, assumptions and projections that are subject to change. Shoul
Slide 3: Discussion Outline
Discussion Outline 3 Q4 and Full Year Financial Results Q4 Sales External Environment and Market Drivers Medicare RAC Medicaid Growth Commercial Market New Executives 2014-2015 Growth and Profitability
Slide 4: Consolidated Statements of Income
Consolidated Statements of Income 4 ($ in thousands except per share amounts) Three months ended Year ended 31-Dec-13 % y/y 31-Dec-13 % y/y Revenue $ 121,592 (9%) $ 491,762 4% Cost of services expenses 84,879 0% 345,883 8% Selling, general & administrative expenses 16,452 45% 68,701 24% Total operat
Slide 5: Quarterly Revenue
Quarterly Revenue 5 (in $ Millions) 0 110 115 120 125 130 135 2013 Avg $122.9M 2012 Avg. $118.4M Q1 107.3 116.6 Q2 120.1 125.8 Q3 113.2 127.8 Q4 133.1 121.6 2012 Act 2013 Act
Slide 6: Quarterly Revenue Without Medicare RAC
Quarterly Revenue Without Medicare RAC 6 (in $ Millions) 0 90 92 94 96 98 100 102 104 106 108 110 2012 Avg. 97.0 2013 Avg. 96.0 Q1 88.1 93.8 Q2 101.6 99.0 Q3 90.0 Q4 108.4 2012 Avg. 97.0 2013 Avg. 96.0 94.7 96.2 2012 Act 2013 Act
Slide 7: 2013 Financial Results
2013 Financial Results 7 Revenue ($M) OpEx ($M) Adj. EPS ($) Adj. EBITDA ($M) 2012 Act: $473.7 2013 Act: $491.8 2012 Act: $374.2 2013 Act: $414.6 2012 Act: $160.2 2013 Act: $144.9 2012 Act: $0.86 2013 Act: $0.75 0 110 115 120 125 130 135 2013 Avg. 2012 Avg. Q1 107.3 116.6 Q2 120.1 125.8 Q3 113.2 127
Slide 8: 2014 Outlook Medicare RAC
Without MC RAC 2014 Outlook 8 Medicare RAC
Slide 9: A Diversified Market and Product Mix
A Diversified Market and Product Mix Medicare RAC Commercial 0-2% 25-30% 2014 Growth Rates v COB Program Integrity 8-10% 20-25% 2013 Revenue By Product 2013 Revenue By Market 2014 Growth Rates 43% 30% 22% 9 5% Other Federal State Medicare RAC 61% 22% 17%
Slide 10: Q4 Sales
Q4 Sales 10 State Government California TPL (reprocurement with additional scope) Florida and Texas long-term care audits Maine TPL (extension) Massachusetts TPL (extension) Minnesota (RAC extension) North Carolina TPL and RAC (contract extensions) Virginia: DRG audit (re-procurement) Wisconsin: RAC
Slide 11: External Environment/Market Drivers
External Environment/Market Drivers 11 Medicare RAC program Medicaid growth and mix Commercial market
Slide 12: Medicare RAC Procurement Timeline
Medicare RAC Procurement Timeline 12
Slide 13: Medicare RAC Program
Medicare RAC Program 13 * CMS data from CMS RAC Program Reports; Medicare RAC program is the most effective way to control costs Momentum seen in the procurement process Enhancements required to improve the program for all stakeholders FFY Total Corrections* (in $ Millions)
Slide 14: Medicaid is Growing
Medicaid is Growing NOTE: Enrollment percentage changes from June to June of each year. Spending growth percentages in state fiscal year. SOURCE: Medicaid Enrollment June 2013 Data Snapshot, KCMU, August 2013. Spending Data from KCMU Analysis of CMS Form 64 Data for Historic Medicaid Growth Rates. F
Slide 15: HMS Advantages in Commercial Sector
15 HMS Advantages in Commercial Sector Enrollment (in millions) Expenditures ($ billions) 1.6% 7% 7.7 % 24.2% Broad array of products Strong MCO relationships End-to-end solutions Proprietary datasets Analytics and clinical expertise
Slide 16: New Leaders
New Leaders 16 20 years in the healthcare information technology Former VP of Architecture & Technology for Regence (Blue Cross Blue Shield) Developed flagship platform and benefits and claims processing system for health plans and self-insured employer groups Cynthia Nustad Former Senior VP of Clai
Slide 17: Summary
Medicaid expansion begins Significant growth in commercial New talent Revenue growth in low teens* Operating margins expanding 5%-6%* v Full-year benefit of new Medicaid lives Acceleration of commercial revenue Across the board revenue growth Further margin expansion Resumption of Medicare RAC growt
Slide 18: Powering healthcare with integrity
@hms Powering healthcare with integrity